Predilatation and paravalvular leakage risk in TAVR – Authors' reply
暂无分享，去创建一个
[1] D. Wood,et al. Impact of Predilatation Prior to Transcatheter Aortic Valve Implantation With the Self-Expanding Acurate neo Device (from the Multicenter NEOPRO Registry). , 2020, The American journal of cardiology.
[2] B. Prendergast,et al. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial , 2019, The Lancet.
[3] D. Tousoulis,et al. Pre-Dilatation Versus No Pre-Dilatation for Implantation of a Self-Expanding Valve in All Comers Undergoing TAVR: The DIRECT Trial. , 2019, JACC. Cardiovascular interventions.
[4] P. Leprince,et al. Impact of Direct Transcatheter Aortic Valve Replacement Without Balloon Aortic Valvuloplasty on Procedural and Clinical Outcomes: Insights From the FRANCE TAVI Registry. , 2018, JACC. Cardiovascular interventions.
[5] A. Einstein,et al. Quantity and location of aortic valve complex calcification predicts severity and location of paravalvular regurgitation and frequency of post-dilation after balloon-expandable transcatheter aortic valve replacement. , 2014, JACC. Cardiovascular interventions.